The Verum™ Panel delivers laboratory conducted oral fluid testing for drugs that were previously undetectable, identifying donor undeclared drug use.
Created to ensure customers can detect new drug-use trends and keep up with a rapidly changing illicit drug market, the testing panel spans 50+ drugs and metabolites, including New Psychoactive Substances (NPS).
This wider panel provides more data to make informed decisions to minimise the risk when prescribing/determining treatment in order to improve donor safety. All of this with just one sample, one step and one panel, leading to faster treatment decisions.
Drug and metabolites available for testing with Verum
Increase in drug detections with Verum in comparison to traditional tests
Drugs and/or metabolites detected were previously not available using traditional laboratory tests
Increase in number of positive samples
Of samples were positive for at least one drug or metabolite
Stimulants |
Opiates |
Illicit sedatives and opioids |
Cannabinoids |
Gabapentinoids and prescription only sedatives |
Opioids |
Antidepressants/antipsychotics |
Get in touch to discuss how Verum can benefit your business.
The percentages and numbers displayed in the ‘Informed Decision’ section of this page are generated from data for oral fluid samples received at our laboratory and testing for the Verum Panel between March 2019 and February 2020.
Based on your current location, the content on this page may not be relevant for your country.
